IP Library Granted Patent US 8,057,818
Granted Patent B2
US 8,057,818 · App. 11/042,181 · Granted Nov 15, 2011

Methods of making expandable foam-like biomaterials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,057,818
App. No.
11/042,181
Granted
Nov 15, 2011
Kind
B2
Abstract

Liquid, injectable, aqueous solutions are transformed in situ to an expandable foam-like, space filling, and adherent biomaterial. Preferably, the foam-like biomaterial is the reaction product of a two-part liquid system to achieve the in situ formation thereof. The liquid system is generally comprised of a protein solution and a cross linker solution which may either be premixed and then applied to a site in need of the biomaterial, or simultaneously mixed and delivered through an in-line mixing/dispensing tip directly to the site. In especially preferred embodiments, an expandable foam-like biomaterial includes the reaction product of human or animal-derived protein material and a di- or polyaldehyde in the presence of a bicarbonate and an acidic titrant amounts sufficient to impart a cellular foam structure to the material.

Claims (30)

1. A method of making a biopolymeric material having a cellular foam structure comprising: combining a proteinaceous pre-polymeric liquid material and a cross linker solution to produce a mixture, wherein the proteinaceous pre-polymeric liquid material comprises a water soluble or plasma protein; introducing or producing a gaseous blowing agent into the proteinaceous pre-polymeric liquid material or the mixture; and allowing the mixture to cross-link and solidify simultaneously with the introduction or production of the gaseous blowing agent to thereby form the biopolymeric material having a cellular foam structure.

2. The method of claim 1 , wherein the proteinaceous pre-polymeric liquid material comprises an aqueous solution of human or animal-derived protein material and the cross linker solution comprises an aqueous solution of a di- or polyaldehyde.

3. The method of claim 2 , wherein the aqueous solution of human or animal-derived protein material further comprises a bicarbonate and the aqueous solution of said di- or polyaldehyde further comprises an acidic titrant.

4. The method of claim 2 or 3 , wherein the biopolymeric material has a volume which is greater than combined volumes of the aqueous solutions.

5. The method of claim 2 , wherein the aqueous solution of human or animal-derived protein material is neutral or slightly alkaline.

6. The method of claim 5 , wherein the aqueous solution of di- or polyaldehyde is acidic.

7. The method of claim 2 , wherein the human or animal-derived protein material comprises albumin.

8. The method of claim 7 , wherein the human or animal-derived protein material comprises serum albumin.

9. The method of claim 2 , wherein the aqueous solution of a di- or polyaldehyde comprises glutaraldehyde.

10. The method of claim 1 , wherein the biopolymeric material is adhesive to human or animal tissue.

11. The method of claim 1 , wherein the step of combining comprises:

expelling the proteinaceous pre-polymeric liquid material from a first chamber and expelling the cross linker solution from a second chamber, and

passing the expelled materials into a mixing tip comprising static mixing elements that cause the proteinaceous pre-polymeric liquid material and the cross linker solution to combine to form the mixture.

12. A method of making a biopolymeric material having a cellular foam structure comprising: combining a proteinaceous pre-polymeric liquid material and an aqueous solution of a di- or polyaldehyde to produce a mixture; introducing or producing a gaseous blowing agent into the mixture; and then allowing the mixture to solidify to thereby form the biopolymeric material having a cellular foam structure, wherein the biopolymeric material has a volume which is greater than the sum of the volumes of the proteinaceous pre-polymeric liquid material and aqueous solution.

13. The method of claim 12 , wherein the biopolymeric material is adhesive to human or animal tissue.

14. The method of claim 12 , wherein the proteinaceous pre-polymeric liquid material comprises human or bovine serum albumin.

15. The method of claim 12 , wherein the aqueous solution of a di- or polyaldehyde comprises glutaraldehyde.

16. A method of making a biopolymeric material having a cellular foam structure comprising:

preparing a two-part mixture which comprises a Part A and a Part B, wherein the Part A includes an aqueous solution of a human- or animal-derived protein material and a bicarbonate compound, and the Part B includes an aqueous solution of a di- or polyaldehyde and a titrant, and wherein the bicarbonate compound and the titrant react to evolve a gas into the two-part mixture; and

allowing the two-part mixture to react and solidify, thereby forming a biopolymeric material having a cellular foam structure which has a volume that is greater than the sum of the volumes of the aqueous solutions of Parts A and B.

17. The method of claim 16 , wherein the bicarbonate compound comprises sodium bicarbonate, potassium bicarbonate, or ammonium bicarbonate.

18. The method of claim 16 , wherein the titrant comprises phosphoric acid, sulfuric acid, hydrochloric acid, citric acid, or acetic acid.

19. The method of claim 16 , wherein the human- or animal-derived protein material comprises albumin.

20. The method of claim 19 , wherein the albumin is human or bovine serum albumin.

21. The method of claim 16 , wherein the di- or polyaldehyde comprises a glutaraldehyde.

22. A foam biomaterial comprising: a human- or animal-derived plasma or water-soluble protein material crosslinked with a di- or polyaldehyde, wherein the di- or polyaldehyde comprises glutaraldehyde, wherein the biomaterial comprises a solid cellular foam structure comprising albumin, and wherein the foam biomaterial is sterilized.

23. The biomaterial of claim 22 , which is made by the method of claim 2 .

24. The biomaterial of claim 22 , wherein the albumin comprises human or bovine serum albumin.

25. The biomaterial of claim 22 , wherein the cellular foam structure comprises both open and closed cells.

26. The biomaterial of claim 22 , which is adhesive to human or animal tissue.

Assignments (7)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2024
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC.
Reel/Frame 066360/0562 →
SECURITY INTEREST Recorded Jan 18, 2024
From: ARTIVION, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 066159/0893 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2017
From: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044616/0940 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →
SECURITY AGREEMENT Recorded Oct 31, 2011
From: CRYOLIFE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 027146/0940 →